Login to Your Account



Financings Roundup

RedX Pharma Raising $17M for Antiviral, Antibody Work

By Nuala Moran
Staff Writer

Wednesday, August 8, 2012

LONDON – RedX Pharma Ltd. is planning a £10.8 million (US$16.8 million) investment to extend the reach of its expertise in the structural modification of marketed drugs into antibiotics and antivirals.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription